These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17764727)

  • 1. Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer.
    Wimberger P; Heubner M; Otterbach F; Fehm T; Kimmig R; Kasimir-Bauer S
    Gynecol Oncol; 2007 Nov; 107(2):331-8. PubMed ID: 17764727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of catumaxomab on tumor cells in bone marrow and blood in ovarian cancer.
    Wimberger P; Heubner M; Lindhofer H; Jäger M; Kimmig R; Kasimir-Bauer S
    Anticancer Res; 2009 May; 29(5):1787-91. PubMed ID: 19443405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
    Thomas C; Wiesner C; Melchior SW; Schmidt F; Gillitzer R; Thüroff JW; Pfitzenmaier J
    BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of disseminated tumor cells in patients with gynecological cancers.
    Fehm T; Becker S; Bachmann C; Beck V; Gebauer G; Banys M; Wallwiener D; Solomayer EF
    Gynecol Oncol; 2006 Dec; 103(3):942-7. PubMed ID: 16889820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer.
    Ross AA; Miller GW; Moss TJ; Kahn DG; Warner NE; Sweet DL; Louie KG; Schneidermann E; Pecora AL; Meagher RC
    Bone Marrow Transplant; 1995 Jun; 15(6):929-33. PubMed ID: 7581093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of disseminated tumor cells in bone marrow of gastric cancer using magnetic activated cell sorting and fluorescent activated cell sorting.
    Wang GY; Li Y; Yu YM; Yu B; Zhang ZY; Liu Y; Wang SJ
    J Gastroenterol Hepatol; 2009 Feb; 24(2):299-306. PubMed ID: 19032456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients.
    Solomayer EF; Becker S; Pergola-Becker G; Bachmann R; Krämer B; Vogel U; Neubauer H; Wallwiener D; Huober J; Fehm TN
    Breast Cancer Res Treat; 2006 Jul; 98(2):179-84. PubMed ID: 16552629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.
    Janni W; Rack B; Schindlbeck C; Strobl B; Rjosk D; Braun S; Sommer H; Pantel K; Gerber B; Friese K
    Cancer; 2005 Mar; 103(5):884-91. PubMed ID: 15666325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
    Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
    Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.
    Müller V; Stahmann N; Riethdorf S; Rau T; Zabel T; Goetz A; Jänicke F; Pantel K
    Clin Cancer Res; 2005 May; 11(10):3678-85. PubMed ID: 15897564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy.
    Aktas B; Kasimir-Bauer S; Heubner M; Kimmig R; Wimberger P
    Int J Gynecol Cancer; 2011 Jul; 21(5):822-30. PubMed ID: 21613958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.
    Schindlbeck C; Kampik T; Janni W; Rack B; Jeschke U; Krajewski S; Sommer H; Friese K
    Breast Cancer Res; 2005; 7(6):R1174-85. PubMed ID: 16457698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer.
    Wu P; Tang RN; Zou JH; Wang FC
    Hepatogastroenterology; 2012 Oct; 59(119):2164-7. PubMed ID: 23178553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients.
    Schulze R; Schulze M; Wischnik A; Ehnle S; Doukas K; Behr W; Ehret W; Schlimok G
    Bone Marrow Transplant; 1997 Jun; 19(12):1223-8. PubMed ID: 9208116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
    Köllermann J; Weikert S; Schostak M; Kempkensteffen C; Kleinschmidt K; Rau T; Pantel K
    J Clin Oncol; 2008 Oct; 26(30):4928-33. PubMed ID: 18794550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
    Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
    J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare expression of target antigens for immunotherapy on disseminated tumor cells in breast cancer patients without overt metastases.
    Kasimir-Bauer S; Otterbach F; Oberhoff C; Schmid KW; Kimmig R; Seeber S
    Int J Mol Med; 2003 Dec; 12(6):969-75. PubMed ID: 14612976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
    Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
    Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rating of isolated disseminated tumor cells in bone marrow in comparison with other factors of prognosis in breast carcinoma.
    Leinung S; Würl P; Schönfelder A; Weiss CL; Röder I; Schönfelder M
    Int J Surg Investig; 2000; 2(3):193-202. PubMed ID: 12678519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.